Driven by Science, United

At OneMedomics, we blend molecular biology and machine learning to craft affordable health solutions for real-world challenges.

At present, we have developed multiple novel technologies for:

• Highly active, novel patented molecules as potential therapeutics for proliferative diseases like cancer, cardiac disease and inflammatory diseases using structure-based drug design, molecular informatics and machine learning.

• Software for automated, highly accurate drug target identification by integrating Omics and molecular data in a machine learning framework.

• Software for automated mining of literature for significantly associated entities using natural language processing and dictionary-based annotation in a robust statistical approach.

• Under development: Novel molecules and software for DNA-based diagnostics.

• Under development: Novel databases with important data for biotech, molecular and health related solutions.